Has Iuliana Shapira, MD received payments from drug or device companies?

Yes. Drug and device makers reported $641,413 in general payments to Iuliana Shapira, MD across 193 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Iuliana Shapira, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Iuliana Shapira, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Iuliana Shapira, MD

Hematology & Oncology · Little Silver, NJNPI 1760553762

Payments from drug & device makers

$641,413in general payments, 2019–2025

Across 193 payments — averaging $3323.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$222K
Epizyme, Inc.$127K
Jazz Pharmaceuticals Inc.$49K
Argenx US, Inc.$43K
AbbVie$41K
Bristol Myers Squibb$25K
plus $134K from 35 others

$2,082in research payments, 2019–2025

Across 1 payment — averaging $2082.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	27	$221,808
Epizyme, Inc.	54	$127,172
Jazz Pharmaceuticals Inc.	17	$49,353
Argenx US, Inc.	7	$43,016
AbbVie	3	$41,337
Bristol Myers Squibb	1	$24,957
Hoffmann-la Roche Limited	1	$23,300
Eli Lilly	4	$22,213
Pfizer	4	$21,817
Sumitomo Pharma America, Inc.	2	$19,120
Sanofi US Services Inc.	12	$11,285
AstraZeneca	5	$5,804
E.r. Squibb & Sons, L.L.C.	5	$5,321
Sanofi	4	$3,616
Beigene USA, Inc.	2	$3,375
Astellas Pharma US Inc	4	$2,296
Foundation Medicine, Inc.	2	$2,282
Eisai Inc.	3	$2,198
Morphosys, US Inc.	1	$2,160
Johnson & Johnson	5	$1,428
Janssen Scientific Affairs, LLC	1	$1,388
Seagen Inc.	1	$1,245
Blueprint Medicines Corporation	1	$1,244
Coherus Oncology, Inc.	1	$1,100
Tolmar Pharmaceuticals, Inc.	1	$1,020
Pharmacosmos Therapeutics Inc.	1	$660
ASD Specialty Healthcare, LLC	1	$203
Amgen	3	$130
Regeneron	1	$108
GSK	1	$65
Takeda Pharmaceuticals U.S.A., Inc.	2	$62
Exelixis Inc.	2	$60
Merck	3	$53
Genentech USA, Inc.	2	$44
Tesaro, Inc.	2	$42
Lilly USA, LLC	2	$37
Puma Biotechnology, Inc.	1	$23
Sanofi-aventis U.S. LLC	1	$20
Ipsen Biopharmaceuticals, Inc	1	$19
Kyowa Kirin, Inc.	1	$19
Karyopharm Therapeutics Inc.	1	$12

How this compares

$641,413 in reported general payments places this provider in the 90th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$310,439

Medicare patients

401

Services billed

10,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Little Silver

Bruno FangEast Brunswick$8.5M
Charles FarberMorristown$4.6M
Rajat BannerjiNew Brunswick$3.3M
Eleonora TeplinskyParamus$2.6M
Mohamad CherryMorristown$1.9M
Evan NaylorManahawkin$1.3M
James OrsiniBelleville$1.3M
Eli KirshnerWestwood$1.2M
Linda DanieuLivingston$1.2M
Steven PapishMorristown$1.2M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →